magnesium sulfate has been researched along with Sensation Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkins, CD | 1 |
Alberts, SR; Chitaley, U; Dentchev, T; Grothey, A; Kugler, JW; Loprinzi, CL; Nikcevich, DA; Novotny, PJ; Silberstein, PT; Sloan, JA; Wender, DB | 1 |
2 trial(s) available for magnesium sulfate and Sensation Disorders
Article | Year |
---|---|
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Calcium Gluconate; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Double-Blind Method; Drug Combinations; Early Termination of Clinical Trials; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2011 |
The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months.
Topics: Anticonvulsants; Disability Evaluation; Disabled Children; Female; Humans; Infant; Magnesium Sulfate; Nervous System Diseases; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Sensation Disorders | 2007 |
1 other study(ies) available for magnesium sulfate and Sensation Disorders
Article | Year |
---|---|
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders | 2014 |